Following its recent Industry Briefing webinar, Pharma.Aero has released a new white paper examining one of the most pressing disruptions currently facing the pharmaceutical logistics sector: geopolitical instability in the Gulf and its implications for global pharmaceutical supply chains.
The webinar brought together more than 100 industry professionals from across the globe to discuss the scale of the disruption, the Gulf’s structural role as a key pharmaceutical transit hub, and the operational and economic consequences for manufacturers and logistics partners. Building on those discussions, the newly published white paper offers a deeper analysis of the challenges at hand, together with practical strategies to strengthen resilience across pharmaceutical supply chains.
Developed with contributions from industry leaders and academic experts, the paper highlights the need for the sector to move beyond pure efficiency and place greater focus on resilience. It explores solutions such as rerouting strategies, regional buffer stocks, digital visibility, and corridor validation, all aimed at helping ensure that life-saving medicines continue to reach patients safely, even during periods of disruption.
Pharma.Aero also acknowledged the valuable contributions of Frank Van Gelder, Prof. Dr. Wouter Dewulf of the University of Antwerp, and participating pharmaceutical manufacturers, whose operational insights helped shape both the webinar discussion and the final paper. The initiative reflects Pharma.Aero’s ongoing commitment to timely, evidence-based knowledge sharing, collaboration, and greater transparency across the life sciences and air cargo community.
The white paper can be accessed here
